Description
Empaglif 25 mg is an oral antidiabetic medication containing Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It is used to control blood sugar levels in adults with type 2 diabetes mellitus and to reduce the risk of cardiovascular death in patients with type 2 diabetes and established heart disease.
Empaglif works by helping the kidneys remove excess glucose through urine, leading to better glycemic control, as well as additional benefits like weight reduction and lower blood pressure.
.jpeg)
 1000 MG.jpg)
.jpeg)
.webp)
 4ML.jpg)
.webp)
.webp)
Change Language